 Home > Medical News > Medical Research Articles > Aishi announced that its original anti-epileptic drug, the anti-epileptic drug Varempanai (Weiketai ®), was accepted for the new drug market in China

Aishi announced that its original anti-epileptic drug, the anti-epileptic drug Varempanai (Weiketai ®), was accepted for the new drug market in China

 Last Update: 2020-06-10
 Source: Internet
 Author: User

Tags

ambient drug

lamivudine brand name

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently,, Aishi Announced that its original anti-epilepticdrug(http://(AED)http://
(AED)name: Fycompa ®; Chinese Product Name: ®) in China,New Drug(http://to be accepted in October 2018the drug is suitable for the use of partial seizures (accompanied or not accompanied by secondary full-blown seizures) patients 12 years of age and olderBased on the significant clinical benefits of the current treatment, the NationalMedicines(http://Supervisory Authority (NMPA) has granted the drug priority review eligibilityabout the Pyrumpanaian innovative anti-epileptic drug developed by the Tsukuba Institute, which is taken daily orallyThe drug is a highly selective, non-competitive AMPA receptor antagonist that reduces overexcitement in neurons associated with seizures by targeting the inhibition of glutamate activity in the synaptic after-membrane AMPA receptorOflampanay has been approved in more than 55 countries worldwide for the addition of partial seizures (accompanied or non-secondary full-blown seizures) in patients 12 years of age and olderIn addition, The total number of progenitors with epilepsy treated in more than 50 countries worldwide has been approved for the use of primary and comprehensive severe stoicsclerosis in patients aged 12 and overin the United States, Verlampane has been approved for single-drug and additional treatment for partial seizures (accompanied or non-secondary full-blown seizures) in patients 4 years and older

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Neopentyl Glycol CAS NO.126-30-7 99% High Quality Factory Supply

CAS No.: 126-30-7

Industrial Grade

$1.7-2/KG FOB

Factory Supply Tirzepatide 10 mg 15mg Weight Loss Peptide 10mg 99.9% CAS: 2023788-19-2

CAS No.: 2023788-19-2

Pharmacy Grade

$4-5/UNIT FOB

good quality 2cb wholesale

CAS No.: 58743-75-2

$2-2.2/MT EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.